Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Avery Dennison (AVY)

Avery Dennison CFO Gregory Lovins takes medical leave; Danny Allouche named interim CFO

Neutral Impact 4 of 5 leadership Written later

Avery Dennison said Chief Financial Officer Gregory Lovins began a medical leave of absence on November 14, 2024, and ceased serving as principal financial officer as of that date. The Board named Senior Vice President and Chief Strategy and Corporate Development Officer Danny G. Allouche as interim CFO, effective November 15, 2024, and he will keep his current role.

Key points

  • Gregory S. Lovins began a medical leave of absence on November 14, 2024.
  • Danny G. Allouche, age 50, was elected Senior Vice President and Interim Chief Financial Officer effective November 15, 2024.
  • The filing does not state how long the interim appointment will last.
  • Allouche's compensation is unchanged: base salary of ILS 1,680,000 (about $450,000), 50% target annual incentive and 120% target long-term incentive.

The filing

CompanyAvery Dennison (AVY)
Form8-K, current report
Filed with the SECNov 15, 2024, 6:46 AM ET
Accession number0000008818-24-000019

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:12 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 15, 2024.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.